/Investor DB

eureKARE

Venture capital

Seed

Find your way into eureKARE

Sign up to see every warm intro you have to eureKARE

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the eureKARE team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

eureKARE focuses on synthetic biology, microbiome research, and the intersection of the two, viewing Europe's strong fundamental science base as underexploited. The firm backs scientists' commercialization efforts to create new companies, jobs, and industries. It targets cutting-edge technologies applicable to healthcare (cell therapies, microbiome-based medicine, gene therapies), agriculture, energy, and environmental sustainability, believing synthetic biology can transform industries and address pressing global challenges. eureKARE seeks to fill Europe's funding and entrepreneurship gap, supporting the growth of synthetic biology companies to build a more sustainable and equitable world.

Source: firm website, verified Aug 3, 2026.

Stage
Seed
Instruments
Equity

Frequently asked questions

What stage does eureKARE invest at?
eureKARE invests at the Seed stage.
What sectors does eureKARE focus on?
eureKARE focuses on AgTech, Biotech, Climate Tech, Deep Tech, Energy, Healthtech.

Images

eureKARE photoeureKARE photo

Similar investors

Featured in lists